Cargando…

The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach

BACKGROUND: Cervical cancer, a preventable disease, is the third leading cause of cancer morbidity and mortality in the Lao People’s Democratic Republic (Lao PDR). Since many cervical cancers are linked to human papilloma virus (HPV) infection, vaccination against this virus may lead to a reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanthavilay, Phetsavanh, Reinharz, Daniel, Mayxay, Mayfong, Phongsavan, Keokedthong, Marsden, Donald E., Moore, Lynne, White, Lisa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994168/
https://www.ncbi.nlm.nih.gov/pubmed/27549921
http://dx.doi.org/10.1186/s12913-016-1662-5
_version_ 1782449272732516352
author Chanthavilay, Phetsavanh
Reinharz, Daniel
Mayxay, Mayfong
Phongsavan, Keokedthong
Marsden, Donald E.
Moore, Lynne
White, Lisa J.
author_facet Chanthavilay, Phetsavanh
Reinharz, Daniel
Mayxay, Mayfong
Phongsavan, Keokedthong
Marsden, Donald E.
Moore, Lynne
White, Lisa J.
author_sort Chanthavilay, Phetsavanh
collection PubMed
description BACKGROUND: Cervical cancer, a preventable disease, is the third leading cause of cancer morbidity and mortality in the Lao People’s Democratic Republic (Lao PDR). Since many cervical cancers are linked to human papilloma virus (HPV) infection, vaccination against this virus may lead to a reduction in these types of cancer. The study described here is the first to compare the cost-effectiveness of different HPV vaccination options in Lao PDR. METHODS: A dynamic compartment model was created. The model included routine screening activities already in place, as well as theoretical interventions that included a 10-year old girl-only vaccination programme combined with/without a 10-year old boy vaccination programme and/or a catch-up component. The simulation was run over 100 years. In base case analyses, we assumed 70 % vaccination coverage with lifelong protection and 100 % efficacy against HPV types 16/18. The outcomes of interest were the incremental cost per Disability-Adjusted Life Year (DALY) averted. RESULTS: In base case analyses, according to the WHO definition of cost-effectiveness thresholds, vaccinating 10-year-old girls was very cost-effective. Adding a catch-up vaccination element for females aged 11–25 years was also very cost-effective, costing 1559 international dollars (I$) per DALY averted. Increasing the age limit of the catch-up vaccination component to 75 years old showed that this remained a cost-effective option (I$ 5840 per DALY averted). Adding a vaccination programme for 10-year-old boys was not found to be cost-effective unless a short time simulation (30 years or less) was considered, along with a catch-up vaccination component for both males and females. CONCLUSIONS: Adding a catch-up female vaccination component is more attractive than adding a 10-year-old boy vaccination component. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12913-016-1662-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4994168
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49941682016-08-24 The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach Chanthavilay, Phetsavanh Reinharz, Daniel Mayxay, Mayfong Phongsavan, Keokedthong Marsden, Donald E. Moore, Lynne White, Lisa J. BMC Health Serv Res Research Article BACKGROUND: Cervical cancer, a preventable disease, is the third leading cause of cancer morbidity and mortality in the Lao People’s Democratic Republic (Lao PDR). Since many cervical cancers are linked to human papilloma virus (HPV) infection, vaccination against this virus may lead to a reduction in these types of cancer. The study described here is the first to compare the cost-effectiveness of different HPV vaccination options in Lao PDR. METHODS: A dynamic compartment model was created. The model included routine screening activities already in place, as well as theoretical interventions that included a 10-year old girl-only vaccination programme combined with/without a 10-year old boy vaccination programme and/or a catch-up component. The simulation was run over 100 years. In base case analyses, we assumed 70 % vaccination coverage with lifelong protection and 100 % efficacy against HPV types 16/18. The outcomes of interest were the incremental cost per Disability-Adjusted Life Year (DALY) averted. RESULTS: In base case analyses, according to the WHO definition of cost-effectiveness thresholds, vaccinating 10-year-old girls was very cost-effective. Adding a catch-up vaccination element for females aged 11–25 years was also very cost-effective, costing 1559 international dollars (I$) per DALY averted. Increasing the age limit of the catch-up vaccination component to 75 years old showed that this remained a cost-effective option (I$ 5840 per DALY averted). Adding a vaccination programme for 10-year-old boys was not found to be cost-effective unless a short time simulation (30 years or less) was considered, along with a catch-up vaccination component for both males and females. CONCLUSIONS: Adding a catch-up female vaccination component is more attractive than adding a 10-year-old boy vaccination component. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12913-016-1662-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-22 /pmc/articles/PMC4994168/ /pubmed/27549921 http://dx.doi.org/10.1186/s12913-016-1662-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chanthavilay, Phetsavanh
Reinharz, Daniel
Mayxay, Mayfong
Phongsavan, Keokedthong
Marsden, Donald E.
Moore, Lynne
White, Lisa J.
The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
title The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
title_full The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
title_fullStr The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
title_full_unstemmed The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
title_short The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach
title_sort economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in lao pdr: a mathematical modelling approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994168/
https://www.ncbi.nlm.nih.gov/pubmed/27549921
http://dx.doi.org/10.1186/s12913-016-1662-5
work_keys_str_mv AT chanthavilayphetsavanh theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT reinharzdaniel theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT mayxaymayfong theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT phongsavankeokedthong theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT marsdendonalde theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT moorelynne theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT whitelisaj theeconomicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT chanthavilayphetsavanh economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT reinharzdaniel economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT mayxaymayfong economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT phongsavankeokedthong economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT marsdendonalde economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT moorelynne economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach
AT whitelisaj economicevaluationofhumanpapillomavirusvaccinationstrategiesagainstcervicalcancerinwomeninlaopdramathematicalmodellingapproach